Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,925 | 164 | 89.9% |
| Education | $328.78 | 5 | 10.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $596.53 | 29 | $0 (2022) |
| UCB, Inc. | $282.08 | 14 | $0 (2024) |
| PFIZER INC. | $217.85 | 13 | $0 (2021) |
| ACADIA Pharmaceuticals Inc | $213.37 | 15 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $155.56 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $154.88 | 10 | $0 (2018) |
| Davol Inc. | $147.61 | 1 | $0 (2023) |
| EMD Serono, Inc. | $137.95 | 8 | $0 (2024) |
| Kyowa Kirin, Inc. | $94.92 | 5 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $87.73 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $250.45 | 8 | PROCEPT BioRobotics Corporation ($125.14) |
| 2023 | $762.68 | 37 | Davol Inc. ($147.61) |
| 2022 | $617.68 | 29 | UCB, Inc. ($144.07) |
| 2021 | $277.63 | 17 | Biogen, Inc. ($36.55) |
| 2020 | $31.86 | 2 | Astellas Pharma US Inc ($18.49) |
| 2019 | $220.95 | 13 | PFIZER INC. ($70.87) |
| 2018 | $696.89 | 42 | Astellas Pharma US Inc ($224.05) |
| 2017 | $395.31 | 21 | Astellas Pharma US Inc ($205.73) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Men's Health | ||||||
| 10/24/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $125.14 | General |
| Category: UROLOGY | ||||||
| 05/16/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Adenosine A2A Receptors | ||||||
| 03/29/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Adenosine A2A Receptors | ||||||
| 03/21/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/05/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Neurology | ||||||
| 01/11/2024 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: NEUROLOGY | ||||||
| 01/04/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.09 | General |
| 12/19/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/18/2023 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 GraftGuide, Kerecis Omega3 SurgiClose | Food and Beverage | Cash or cash equivalent | $15.31 | General |
| Category: Wound Care | ||||||
| 12/05/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: Neurology | ||||||
| 12/02/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Central Nervous System | ||||||
| 11/22/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $23.96 | General |
| 11/21/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: Neurology | ||||||
| 11/21/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $4.12 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/20/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/13/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 10/28/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: NEUROLOGY | ||||||
| 10/20/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Central Nervous System | ||||||
| 10/12/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: Neurology | ||||||
| 10/10/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $15.16 | General |
| Category: Neurology | ||||||
| 10/02/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/29/2023 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Adenosine A2A Receptors | ||||||
| 09/09/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Central Nervous System | ||||||
| 08/28/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $32.06 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 313 | 497 | $85,568 | $31,267 |
| 2022 | 9 | 440 | 569 | $119,928 | $41,995 |
| 2021 | 10 | 436 | 583 | $105,611 | $38,621 |
| 2020 | 12 | 425 | 544 | $113,936 | $39,661 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 292 | $40,296 | $19,269 | 47.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 19 | 24 | $15,264 | $4,415 | 28.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 21 | 32 | $14,624 | $3,391 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $7,608 | $2,944 | 38.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 74 | 102 | $5,916 | $803.16 | 13.6% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 20 | 23 | $1,860 | $444.36 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 161 | 249 | $34,362 | $15,864 | 46.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 35 | 44 | $27,984 | $8,030 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $20,922 | $7,985 | 38.2% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2022 | 13 | 13 | $9,828 | $3,355 | 34.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 18 | 22 | $10,054 | $2,442 | 24.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 21 | $5,586 | $2,117 | 37.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,472 | $943.80 | 38.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 100 | 125 | $7,250 | $934.29 | 12.9% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 15 | 17 | $1,470 | $323.52 | 22.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 140 | 226 | $31,188 | $14,679 | 47.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 69 | 69 | $21,873 | $8,506 | 38.9% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 27 | 27 | $17,172 | $4,811 | 28.0% |
| 52310 | Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope | Office | 2021 | 20 | 20 | $15,120 | $4,761 | 31.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 14 | $2,856 | $1,453 | 50.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 24 | $3,336 | $1,374 | 41.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 108 | 155 | $8,990 | $1,150 | 12.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $2,472 | $934.48 | 37.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 20 | 22 | $1,694 | $672.98 | 39.7% |
| 74420 | Imaging of urinary tract | Facility | 2021 | 13 | 14 | $910.00 | $280.98 | 30.9% |
About Dr. Alosh Madala, MD
Dr. Alosh Madala, MD is a Urology healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1285894030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alosh Madala, MD has received a total of $3,253 in payments from pharmaceutical and medical device companies, with $250.45 received in 2024. These payments were reported across 169 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($2,925).
As a Medicare-enrolled provider, Madala has provided services to 1,614 Medicare beneficiaries, totaling 2,193 services with total Medicare billing of $151,543. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Kansas City, MO
- Active Since 06/16/2008
- Last Updated 06/24/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1285894030
Products in Payments
- XTANDI (Drug) $353.81
- Briviact (Drug) $230.78
- NUPLAZID (Drug) $213.37
- ARISTA AH FlexiTip (Device) $147.61
- Erleada (Drug) $143.08
- AQUABEAM SYSTEM (Device) $125.14
- Myrbetriq (Drug) $100.26
- Nourianz (Drug) $77.75
- ZYTIGA (Drug) $71.79
- PROVENGE (Drug) $62.71
- MAVENCLAD (Drug) $59.54
- TYSABRI (Biological) $56.99
- MYRBETRIQ (Drug) $50.78
- Prolia (Biological) $48.12
- Austedo XR (Drug) $47.27
- Xtandi (Drug) $47.02
- iTIND System (Device) $38.66
- GEMTESA (Drug) $34.32
- PLUVICTO (Drug) $32.06
- AQUABEAM ROBOTIC SYSTEM (Device) $30.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Kansas City
Wilson Molina, Md, MD
Urology — Payments: $340,886
Dr. Samuel Kuykendall, M.d, M.D
Urology — Payments: $159,847
Bristol Whiles, Md, MD
Urology — Payments: $102,131
Ahmad El-Arabi, M.d, M.D
Urology — Payments: $53,792
Dr. Jeffrey Holzbeierlein, Md, MD
Urology — Payments: $50,322
Dr. David Duchene, Md, MD
Urology — Payments: $33,788